期刊文献+

无锡地区21568例孕妇孕中期产前筛查结果分析 被引量:1

原文传递
导出
摘要 目的探讨孕中期孕妇血清标志物甲胎蛋白(AFP)和游离人绒毛促性腺激素β亚单位(Free-βhCG)和雌三醇(uE3)检测在产前筛查中的作用。方法应用时间分辨荧光免疫分析系统对21 568例孕中期(14~20+6周)妇女进行血清AFP、uE3和Free-βhCG的检测及分析,风险率≥1∶270为唐氏综合征筛查高风险,追踪胎儿和孕妇的情况,产前诊断及新生儿检查以确认。结果 21 568例筛查孕妇中,唐氏综合征筛查高风险1392例,检出6例21三体,18-三体3例,其他异常染色体36例。胎儿异常检出率为2.59%。结论孕中期产前筛查是预测异常胎儿和不良妊娠结局的有效方法,再结合产前诊断对防止先天缺陷有实用性价值。
作者 孟西娜 唐叶
出处 《中国优生与遗传杂志》 2012年第12期80-81,共2页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献7

  • 1梁雄,朱锋,朱兰芳,郭小宝,肖鸽飞.3195例孕中期唐氏综合征的血清筛查和产前诊断临床分析[J].中国现代医学杂志,2005,15(20):3079-3081. 被引量:47
  • 2Brambati B, Macintosh Mch, Teisner B, et al. Low maternal serum levels of pregnancy associated plasma protein A ( PAPP - A ) in the first trimester in association with abnormal fetal karyotype [ J ]. Br J Obstet Gynaecol, 1993,100:324 - 326.
  • 3Wald NJ, Geprge L, Smith D, et al. Serum screening for Down's syndrome between 8 and lg weeds of pregnaacy [ J ]. Br J Obstet Gynaecol, 1996,103:407-412.
  • 4Bahado - Singh R, Shahabi S, Karaca M, et al. The comprehensive midtrimester test : high - sensitivity Down syndrome test [ J ]. Am J Ob- stet Gynecol,2002,186 (4) : 803 - 808.
  • 5Jaunianx E, Brown R, Snijders RJM, et al. Early prenatal diagnosis of triploidy[ J ]. Am J Obster Gynecol, 1997,176:550 - 554.
  • 6Cuckle H. Biochemical screening for Down's syndrome [ J 1. Eur J Obstet Gynecol Reprod Biol, 2000, 92: 97.
  • 7Gilbert RE, Augood C, Ades AE, et al. Screening for Down's syn- drome : effects, safety, and cost effectiveness of first and second tri- mester strategies[ J ]. BMJ, 2001, 323: 423.

二级参考文献6

  • 1SALLER DN. Maternal serum screening for fetal Down's syndrome: clinical aspects [J]. Clin Obstet Gynecol, 1996, 39:783-793.
  • 2Wald NJ, Cuchle HS, Densem JM, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome[J]. Br J Obste Gynaecol, 1988, 95(4): 334-341.
  • 3WALD NJ, WATT HC, HACKSHAW AK. Integrateded screening for down's syndrome based on tests performed during the fist and second trimester [J]. New Engl J Med, 1999, 341 (7):461-467.
  • 4CATANZARITE VA, JELOVESEK FR. Computing applications in obsterics[J]. Am J Obstet Gynecol, 1987, 156: 1049.
  • 5PALACIO M, JAUNIAUX E, KINGDOM J, et al. Perinatal out come in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free-beta-human chorionic gonadotropin[J]. Ultrasound-Obstet-Gynecol, 1999, 13: 58-62.
  • 6商敏,马彦彦.唐氏综合征血清筛查[J].中华围产医学杂志,2003,6(3):190-192. 被引量:69

共引文献46

同被引文献12

  • 1黄瑞萍,张雅英,孙达成.281例胎儿染色体病的产前诊断分析[J].中国妇幼保健,2006,21(17):2381-2382. 被引量:8
  • 2Lo Y M,Corbetta N,Chamberlain P F,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485.
  • 3Benn PA,Chapman AR.Ethical challenges in providing noninvasive prenatal diagnosis[J].Curr Opin Obstet Gynecol,2010,22(2):128.
  • 4Wright D,Bradbury I,Malone F,et al.Cross-trimester repeated measures testing for Down's syndrome screening:an assessment[J].Health Technol Assess,2010,14(33):1.
  • 5Lau T K,Chan M K,Salome L P S,et al.Clinical utility of noninvasive fetal trisomy(NIFTY)test-early experience[J].J Matern Fetal Neonatal Med,2012,25(10):1856.
  • 6Dan S,Wang W,Ren J,et al.Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors[J].Prenat Diagn,2012,32:1225.
  • 7Bianchi D W,Platt L D,Goldberg J D,et al.Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing[J].Obstet Gynecol,2012,119:890.
  • 8Jiang F,Ren J,Chen F,et al.Noninvasive Fetal Trisomy(NIFTY)test:an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies[J].BMC Med Genomics,2012,5:57.
  • 9刘启兰,胡娅莉,许争峰,王丽娟,孙庆,林宁,徐晓燕,刘艳,张建伟,童建孙,王兴海,何竞.江苏地区以人群为基础的唐氏综合征产前筛查和诊断研究[J].中华医学遗传学杂志,2010,27(3):340-342. 被引量:27
  • 10吴清明,周瑾,刘伟,王瑞,杨柳,刘鸿春,余良宽.妊娠中期1641例产前筛查及95例产前诊断结果分析[J].现代生物医学进展,2010,10(14):2679-2681. 被引量:8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部